Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cytokines are small proteins and major mediators of local intercellular communication required for an integrated response to a variety of stimuli in immune and inflammatory responses. By binding their cognate receptors on target cells, these short-lived molecules play a role in many important biological processes, including cell proliferation, activation, death, and differentiation. During an inflammatory response many cytokines are synthesized by a wide range of cell types, including leukocytes and fibroblasts. Some cytokines are proinflammatory, such as interleukin-1 (IL-1) and tumor necrosis factor a (TNF-α); others, such as interleukin-10 (IL-10) and transforming growth factor β(TGF-β), exert predominantly anti-inflammatory effects. However, it is now understood that many cytokines, for example, interferon-γ (IFN-γ), with chiefly proinflammatory activity, can also in some instances have anti-inflammatory properties. Similarly, cytokines with predominantly anti-inflammatory activity, such as IL-10 and TGF-β may also exhibit proinflammatory properties and therefore have pathogenic potential. Paracrine or autocrine pathways involving cytokines with either pro- or anti-inflammatory activity can lead to reverberating networks determining whether chronic inflammation results.

Original publication

DOI

10.1385/1-59259-076-4:115

Type

Journal article

Journal

Methods mol med

Publication Date

2000

Volume

40

Pages

115 - 139